HCA Inc./DE Form 424B3 — Nov 2, 2026
HCA Inc., a wholly owned subsidiary of HCA Healthcare (HCA), filed a preliminary prospectus supplement for a senior notes offering spanning seven tranches, including floating rate notes tied to Compounded SOFR. The pricing, amounts, and maturities are still blank as the deal is subject to completion. Proceeds are earmarked for general corporate purposes, including a possible redemption of $1.200 billion of 4.500% senior notes due 2027 and repayment of borrowings under the $8.000 billion commercial paper program and revolving credit facility.
Key figures
- Debt Amount
- aggregate principal amount of seven tranches of senior notes (amounts not yet stated)
- Interest Rate
- floating rate notes bear Compounded SOFR plus a spread; fixed tranche rates not yet stated
- Total debt actual
- $50.493 billion as of September 30, 2026
- Cash and equivalents
- $908 million
- Other unsecured debt
- $450 million debentures, maturities 2027 to 2095, weighted average rate 7.41%
- Change of control put
- 101% of principal plus accrued interest
- Existing senior notes
- $43.750 billion, maturities 2027 to 2064, weighted average rate 4.92%
- Secured subsidiary debt
- $1.005 billion (weighted average rate 4.99%)
- Commercial paper program
- $8.000 billion
- Revolving credit facility
- $8.000 billion senior unsecured revolver maturing February 20, 2030
- Amount to redeem 2027 notes
- $1.200 billion of 4.500% senior notes due 2027
- Commercial paper outstanding
- $5.727 billion (avg life 26 days, weighted average rate 4.21%)
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.